Disturbed expression of the T-cell receptor/CD3 complex and associated signaling molecules in CD30(+) T-cell lymphoproliferations
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: In: Haematologica - The hematology journal (2010) 95, 10, 1697-1704, DOI: 10.3324/haematol.2009.021428
- Schlagwort
-
Medizin
Krebs
Onkologie
- Ereignis
-
Veröffentlichung
- (wo)
-
Würzburg
- (wer)
-
Universität Würzburg
- (wann)
-
2012
- Urheber
-
Geissinger, Eva
Sadler, Petra
Roth, Sabine
Grieb, Tina
Puppe, Bernhard
Mueller, Nora
Reimer, Peter
Vetter-Kauczok, Claudia S.
Wenzel, Joerg
Bonzheim, Irina
Ruediger, Thomas
Mueller-Hermelink, Hans Konrad
Rosenwald, Andreas
- URN
-
urn:nbn:de:bvb:20-opus-68179
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:51 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Geissinger, Eva
- Sadler, Petra
- Roth, Sabine
- Grieb, Tina
- Puppe, Bernhard
- Mueller, Nora
- Reimer, Peter
- Vetter-Kauczok, Claudia S.
- Wenzel, Joerg
- Bonzheim, Irina
- Ruediger, Thomas
- Mueller-Hermelink, Hans Konrad
- Rosenwald, Andreas
- Universität Würzburg
Entstanden
- 2012
Ähnliche Objekte (12)
Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors
T-cell receptor avidity of polyclonal CD8+ T-cell populations
Human T-cell clones
CAR T-Cell therapy
CD30 + Primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report
The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia
Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy
Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors
T-cell receptor avidity of polyclonal CD8+ T-cell populations
Human T-cell clones
CAR T-Cell therapy
CD30 + Primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report
The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia
Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy
Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells
Differential CD30 expression in adult T-cell leukemia-lymphoma subtypes
Autologous stem cell transplantation in tandem with Anti-CD30 CAR T-cell infusion in relapsed/refractory CD30+ lymphoma
T-cell stimulating vaccines empower CD3 bispecific antibody therapy in solid tumors
T-cell receptor avidity of polyclonal CD8+ T-cell populations
Human T-cell clones
CAR T-Cell therapy
CD30 + Primary intestinal T-cell lymphoma (unclassified) masquerading as chronic inflammation: a case report
The T-cell receptor and it's signaling in T-cell prolymphocytic Leukemia
Identification of Suitable T-Cell Subsets for Personalized Antiviral T-Cell Immunotherapy
Excessive activated T-cell proliferation after anti-CD19 CAR T-cell therapy
CD33/CD3-bispecific T-cell engaging (BiTE®) antibody construct targets monocytic AML myeloid-derived suppressor cells